50M cap raise at 4.10 per share according to AFR. Not very big and not much of a discount. Are retail holders going to get a look in I wonder.
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
